Fidelis Capital Partners, LLC Astrazeneca PLC Transaction History
Fidelis Capital Partners, LLC
- $941 Billion
- Q1 2025
A detailed history of Fidelis Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 3,662 shares of AZN stock, worth $257,731. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,662
Previous 2,916
25.58%
Holding current value
$257,731
Previous $204 Million
25.06%
% of portfolio
0.03%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.86 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.2 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...